Literature DB >> 5064457

Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells.

R S Northrup, A S Fauci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5064457     DOI： 10.1093/infdis/125.6.672

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

1.  Involvement of antigen-presenting cells in the enhancement of the in vitro antibody responses by cholera toxin B subunit.

Authors:  Y Hirabayashi; S I Tamura; K Shimada; T Kurata
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.

Authors:  Sandip K Datta; Mojgan Sabet; Kim Phung L Nguyen; Patricia A Valdez; Jose M Gonzalez-Navajas; Shamima Islam; Ivan Mihajlov; Joshua Fierer; Paul A Insel; Nicholas J Webster; Donald G Guiney; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Systemic delayed-type hypersensitivity to cholera toxin and a detoxified derivative.

Authors:  R A Kay; A Ferguson
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  Suppression of local intestinal immunoglobulin A immune response to cholera toxin by subcutaneous administration of cholera toxoids.

Authors:  S R Hamilton; J H Yardley; G D Brown
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

5.  Role for macrophages and thymus-derived lymphocytes in cholera toxin-induced immunosuppression.

Authors:  S F Lyons; H Friedman
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

6.  Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.

Authors:  R S Rappaport; G Bonde; T McCann; B A Rubin; H Tint
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

7.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony; A Anderson; G Walletström; U Westerberg-Berndtsson
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

8.  Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.

Authors:  Mari Ohmura; Masafumi Yamamoto; Chikako Tomiyama-Miyaji; Yoshikazu Yuki; Yoshifumi Takeda; Hiroshi Kiyono
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

9.  Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Authors:  C C Häse; L S Thai; M Boesman-Finkelstein; V L Mar; W N Burnette; H R Kaslow; L A Stevens; J Moss; R A Finkelstein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 10.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.